Trials / Conditions / Metastatic Liposarcoma

Metastatic Liposarcoma

7 registered clinical trials studyying Metastatic Liposarcoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma NCT06414434	Michael Wagner, MD	Phase 1
Terminated	Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot NCT03074318	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B NCT03009201	OHSU Knight Cancer Institute	Phase 1
Completed	Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas NCT02978859	Columbia University	Phase 2
Completed	Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su NCT02500797	National Cancer Institute (NCI)	Phase 2
Completed	Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone NCT02357810	Northwestern University	Phase 2
Completed	Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma NCT01506596	Vector Oncology	Phase 2